| 1. How many years have you been practicing psychiatry? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| 1-5 |  | 2.2% | 1 |
| 6-10 | | 13.0% | 6 |
| 11-20 | | 26.1% | 12 |
| 21-30 | | 34.8% | 16 |
| More than 30 | | 23.9% | 11 |
| answered question | 46 | ||
| skipped question | 0 | ||
| 2. Which is your preferred selective serotonin reuptake inhibitor (SSRIs) drug for treating patients with depression? Please pick only one. | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| citalopram (Celexa, Cipramil, Emocal, Sepram, Seropram) | | 15.6% | 7 |
| escitalopram oxalate (Lexapro, Cipralex, Esertia) | | 33.3% | 15 |
| fluoxetine (Prozac, Fontex, Seromex, Seronil, Sarafem, Fluctin (EUR), Fluox (NZ)) | | 17.8% | 8 |
| fluvoxamine maleate (Luvox, Faverin) | 0.0% | 0 | |
| paroxetine (Paxil, Seroxat, Aropax, Deroxat, Rexetin, Xetanor, Paroxat) | | 2.2% | 1 |
| sertraline (Zoloft, Lustral, Serlain) | | 20.0% | 9 |
| dapoxetine | 0.0% | 0 | |
| duloxetine hydrochloride (Cymbalta) | | 11.1% | 5 |
| answered question | 45 | ||
| skipped question | 1 | ||
| 3. Do you use SSRI drugs for off-label indications? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 71.7% | 33 |
| No | | 28.3% | 13 |
 Other (please specify) | 2 | ||
| answered question | 46 | ||
| skipped question | 0 | ||
| 4. Are the majority of your SSRI drug prescriptions for | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| On-label use of the drugs as defined by the FDA. | | 97.8% | 44 |
| Off-label use of the drugs. | | 2.2% | 1 |
| Other (please specify) | 1 | ||
| answered question | 45 | ||
| skipped question | 1 | ||
| 5. A study, "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration," published in the most recent issue of the "PLoS Medicine" journal, http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050045 concluded that "... compared with placebo, the new-generation antidepressants do not produce clinically significant improvements in depression in patients who initially have moderate or even very severe depression, but show significant effects only in the most severely depressed patients."Based on your experience with your patients who are on SSRI drugs, do you agree or disgaree with this article's conclusion? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| I AGREE with this study's conclusion. | | 13.0% | 6 |
| I DISAGREE with this study's conclusion. | | 87.0% | 40 |
| Other (please specify) | 3 | ||
| answered question | 46 | ||
| skipped question | 0 | ||
| 6. What will you do as a result of reviewing this study? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Increase usage of SSRI drugs. | 0.0% | 0 | |
| Decrease usage of SSRI drugs. | | 2.2% | 1 |
| This study will not affect my usage of SSRI drugs. | | 97.8% | 44 |
| Other (please specify) | 2 | ||
| answered question | 45 | ||
| skipped question | 1 | ||
| 7. The results of this study will be submitted to the FDA. What action do you think the FDA should take based on this study? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Restrict SSRI on-label use for only "severe" depression. | | 2.2% | 1 |
| Take no action based on this study. | | 50.0% | 23 |
| Do additional studies. | | 56.5% | 26 |
| Other (please specify) | 4 | ||
| answered question | 46 | ||
| skipped question | 0 | ||
| 8. If the FDA imposes additional restrictions for prescribing SSRI drugs as a result of this study, will that affect how you prescribe these drugs? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 32.6% | 14 |
| No | | 67.4% | 29 |
| Other (please specify) | 4 | ||
| answered question | 43 | ||
| skipped question | 3 | ||
| 9. Global sales of antidepressants were approximately $21 billion in 2007. How do you think this study will affect SSRI drug sales? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Will INCREASE sales. | 0.0% | 0 | |
| Will DECREASE sales. | | 50.0% | 23 |
| Will have no significant impact on sales. | | 50.0% | 23 |
| Other (please specify) | 0 | ||
| answered question | 46 | ||
| skipped question | 0 | ||
| 10. Some studies have concluded that SSRI drugs may increase the incidence of suicide and violence in pediatric, adolescent and young adult patients. Do you agree with that? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 38.1% | 16 |
| No | | 61.9% | 26 |
| Other (please specify) | 7 | ||
| answered question | 42 | ||
| skipped question | 4 | ||
| 11. Do you prescribe SSRI drugs to pediatric, adolescent and young adult patients? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 65.9% | 29 |
| No | | 34.1% | 15 |
| Other (please specify) | 4 | ||
| answered question | 44 | ||
| skipped question | 2 | ||
| 12. Do you like to participate in online healthcare surveys? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 72.7% | 32 |
| No | | 27.3% | 12 |
| Other (please specify) | 2 | ||
| answered question | 44 | ||
| skipped question | 2 | ||
| 13. Would you like to participate in other WhatDoctorsThink.com online surveys? You can see some other surveys we've performed at http://whatdoctorsthink.com/surveysamples.html | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 70.5% | 31 |
| No | | 29.5% | 13 |
| Other (please specify) | 3 | ||
| answered question | 44 | ||
| skipped question | 2 | ||
| 14. Would you like to participate in various other types of online surveys where you receive honorariums for your time and expertise? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 78.6% | 33 |
| No | | 21.4% | 9 |
| Other (please specify) | 3 | ||
| answered question | 42 | ||
| skipped question | 4 | ||